Clinical significance of Histone Deacetylase ( HDAC)-1,-2,-4 and-6 expression in salivary gland tumours

被引：0
|
作者：
Pouloudi, D. [1 ]
Manou, M. [1 ]
Sarantis, P. [1 ]
Tsoukalas, N. [1 ]
Tsourouflis, G. [2 ]
Dana, E. [1 ]
Karamouzis, M. [3 ]
Klijanienko, J. [4 ]
Theocharis, S. [1 ]
机构：
[1] Univ Athens, Sch Med, Dept Pathol 1, Athens, Greece
[2] Univ Athens, Sch Med, Dept Propedeut Surg 2, Athens, Greece
[3] Univ Athens, Sch Med, Dept Biol Chem, Athens, Greece
[4] Inst Curie, Dept Pathol, Paris, France
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-03-018
引用
收藏
页码：S93 / S94
页数：2
相关论文
共 50 条
  • [41] Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors
    Wagner, Florence F.
    Weiwer, Michel
    Steinbacher, Stefan
    Schomburg, Adrian
    Reinemer, Peter
    Gale, Jennifer P.
    Campbell, Arthur J.
    Fisher, Stewart L.
    Zhao, Wen-Ning
    Reis, Surya A.
    Hennig, Krista M.
    Thomas, Meryl
    Muller, Peter
    Jefson, Martin R.
    Fass, Daniel M.
    Haggarty, Stephen J.
    Zhang, Yan-Ling
    Holson, Edward B.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (18) : 4008 - 4015
  • [42] Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
    Wen-Feng Fang
    Yu-Mu Chen
    Chiung-Yu Lin
    Hui-Lin Huang
    Hua Yeh
    Ya-Ting Chang
    Kuo-Tung Huang
    Meng-Chih Lin
    Journal of Inflammation, 15
  • [43] Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
    Fang, Wen-Feng
    Chen, Yu-Mu
    Lin, Chiung-Yu
    Huang, Hui-Lin
    Yeh, Hua
    Chang, Ya-Ting
    Huang, Kuo-Tung
    Lin, Meng-Chih
    JOURNAL OF INFLAMMATION-LONDON, 2018, 15
  • [44] Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
    Urias, Beatriz Silva
    Pavan, Aline Renata
    Albuquerque, Gabriela Ribeiro
    Prokopczyk, Igor Muccilo
    Ferreira Alves, Tania Mara
    Ferreira de Melo, Thais Regina
    Rodrigues Sartori, Geraldo
    Martins da Silva, Joao Herminio
    Chin, Chung Man
    Dos Santos, Jean Leandro
    PHARMACEUTICALS, 2022, 15 (10)
  • [45] HTLV-1 inhibits stress granules formation by interacting with the histone deacetylase 6 (HDAC6)
    Legros, Sebastien
    Boxus, Mathieu
    Twizere, Jean-Claude
    Dequiedt, Franck
    Kettmann, Richard
    RETROVIROLOGY, 2009, 6
  • [46] HTLV-1 inhibits stress granules formation by interacting with the histone deacetylase 6 (HDAC6)
    Sébastien Legros
    Mathieu Boxus
    Jean-Claude Twizere
    Franck Dequiedt
    Richard Kettmann
    Retrovirology, 6
  • [47] Expression and significance of cortactin and HDAC6 in human prostatic foamy gland carcinoma
    Hou, Huilian
    Zhao, Le
    Chen, Wei
    Li, Jing
    Zuo, Qinqin
    Zhang, Guanjun
    Zhang, Xuebin
    Li, Xu
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2015, 96 (04) : 248 - 254
  • [48] Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
    Seo, Jinwon
    Min, Soo Kee
    Park, Hye-Rim
    Kim, Dong Hoon
    Kwon, Mi Jung
    Kim, Lee Su
    Ju, Young-Su
    JOURNAL OF BREAST CANCER, 2014, 17 (04) : 323 - 331
  • [49] Clinical and preclinical development of 4SC-201, a new oral histone deacetylase (HDAC) inhibitor
    de Bono, J.
    Brunetto, A. T.
    Kristeleit, R.
    Mais, A.
    Hauns, B.
    Hentsch, B.
    EJC SUPPLEMENTS, 2009, 7 (02): : 137 - 137
  • [50] Stage specific expression of histone deacetylase 4 (HDAC4) during oogenesis and early preimplantation development in mice
    Kageyama, S
    Liu, HL
    Nagata, M
    Aoki, F
    JOURNAL OF REPRODUCTION AND DEVELOPMENT, 2006, 52 (01): : 99 - 106
12345